Last Updated: June 25, 2026

ALMOTRIPTAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Almotriptan

A generic version of ALMOTRIPTAN was approved as almotriptan malate by TEVA PHARMS USA on July 7th, 2015.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for ALMOTRIPTAN?
  • What are the global sales for ALMOTRIPTAN?
  • What is Average Wholesale Price for ALMOTRIPTAN?
Summary for ALMOTRIPTAN
US Patents:0
Applicants:3
NDAs:3
Drug Prices: Drug price information for ALMOTRIPTAN
DailyMed Link:ALMOTRIPTAN at DailyMed

US Patents and Regulatory Information for ALMOTRIPTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205523-001 Mar 3, 2016 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mylan ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205171-002 Nov 9, 2015 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ajanta Pharma Ltd ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205523-002 Mar 3, 2016 AB RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mylan ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 205171-001 Nov 9, 2015 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva Pharms Usa ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 078027-002 Jul 7, 2015 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva Pharms Usa ALMOTRIPTAN MALATE almotriptan malate TABLET;ORAL 078027-001 Jul 7, 2015 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.